Pediatric Hypothalamic Obesity
NCT00076362
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
60
Enrollment
INDUSTRY
Sponsor class
Conditions
Obesity
Interventions
DRUG:
Sandostatin LAR
Sponsor
Novartis Pharmaceuticals